| Developers: | Florida Atlantic University |
| Date of the premiere of the system: | December 2022 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
2022: Smart Belt Announcement
In late December 2022, researchers at Florida Atlantic University unveiled a belt that can track heart failure patients for signs of disease progression.
The wearable device measures heart rate, chest impedance, electrocardiogram and movement, all of which can provide information about the condition of a patient with heart failure and possibly detect an early exacerbation of the disease. For December 2022, scientists tested the device in a variety of everyday settings, including common activities such as sitting, lying, standing and walking, and found it worked well enough. Researchers hope the technology could help reduce readmissions of heart failure patients by identifying problems before they get worse.
More than 6 million people in the United States live with heart failure. This disease can be debilitating and life-changing, and it is progressing. Many heart failure patients are forced to be readmitted as their condition worsens. Finding a way to monitor such patients while they are at home can pay dividends in the form of early intervention and patient improvement. Although some monitors are already available, not all patients are suitable for their use, and some are invasive, requiring implantation of the device. There is a clear need for better solutions.
 | About one in four heart failure patients are readmitted within 30 days of hospital discharge, and about half within six months. Wearable healthcare devices are able to reduce the number of readmissions in a cost-effective way that is also safe and user-friendly! All the sensors we have integrated into our waist module can be easily worn for a long period of time without compromising the patient's daily activities, said lead technology developer, Dr. Mary Ann McGuire Leavitt. |  |
The device comprises sensors that detect various physiological signals in real time. The researchers tested whether the technology could provide stable and reliable readings during a variety of daily activities. Within 6 months, the device remained with positive ratings for its work from various doctors and users.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |